| Primary |
| Product Used For Unknown Indication |
29.5% |
| Hypertension |
19.7% |
| Type 2 Diabetes Mellitus |
18.0% |
| Diabetes Mellitus |
8.2% |
| Depression |
6.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Dementia |
1.6% |
| Dermatosis |
1.6% |
| Dyslipidaemia |
1.6% |
| Genital Haemorrhage |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Hyperuricaemia |
1.6% |
| Major Depression |
1.6% |
| Osteoarthritis |
1.6% |
| Phlebitis |
1.6% |
| Rheumatoid Arthritis |
1.6% |
|
| Gout |
11.1% |
| Vomiting |
11.1% |
| Fatigue |
5.6% |
| Jaundice |
5.6% |
| Malaise |
5.6% |
| Metabolic Acidosis |
5.6% |
| Nausea |
5.6% |
| Oedema |
5.6% |
| Poisoning |
5.6% |
| Product Substitution Issue |
5.6% |
| Renal Tubular Necrosis |
5.6% |
| Shortened Cervix |
5.6% |
| Tachycardia Paroxysmal |
5.6% |
| Toxicity To Various Agents |
5.6% |
| Ventricular Tachycardia |
5.6% |
| Weight Decreased |
5.6% |
|
| Secondary |
| Product Used For Unknown Indication |
37.1% |
| Type 2 Diabetes Mellitus |
22.6% |
| Drug Use For Unknown Indication |
6.3% |
| Hypertension |
6.3% |
| Depression |
5.0% |
| Diabetes Mellitus |
3.1% |
| Hiv Infection |
3.1% |
| Insulin-requiring Type 2 Diabetes Mellitus |
3.1% |
| Osteoarthritis |
1.9% |
| Breast Cancer |
1.3% |
| Cholangiocarcinoma |
1.3% |
| Cystitis |
1.3% |
| Epilepsy |
1.3% |
| Gastroduodenal Ulcer |
1.3% |
| Hypokalaemia |
1.3% |
| Rheumatoid Arthritis |
1.3% |
| Anticoagulant Therapy |
0.6% |
| Arrhythmia |
0.6% |
| Cardiac Failure |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
|
| Renal Failure Acute |
21.4% |
| Vomiting |
14.3% |
| Renal Failure |
7.1% |
| Transient Ischaemic Attack |
7.1% |
| Foetal Malformation |
4.8% |
| Lymphopenia |
4.8% |
| Malaise |
4.8% |
| Urinary Incontinence |
4.8% |
| Weight Decreased |
4.8% |
| Anaemia |
2.4% |
| Anaemia Haemolytic Autoimmune |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Drug Ineffective |
2.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.4% |
| Exposure During Pregnancy |
2.4% |
| Hepatitis Acute |
2.4% |
| Hepatitis Fulminant |
2.4% |
| Hypertransaminasaemia |
2.4% |
| Hypotonia |
2.4% |
| Jaundice |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.4% |
| Hypertension |
13.0% |
| Type 2 Diabetes Mellitus |
12.1% |
| Diabetes Mellitus |
7.7% |
| Atrial Fibrillation |
4.0% |
| Psoriasis |
3.4% |
| Depression |
3.2% |
| Hiv Infection |
3.2% |
| Pain |
2.7% |
| Drug Use For Unknown Indication |
2.4% |
| Dyslipidaemia |
1.9% |
| Prophylaxis |
1.9% |
| Rheumatoid Arthritis |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Back Pain |
1.1% |
| Angina Pectoris |
1.0% |
| Cardiac Failure |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Coronary Artery Disease |
1.0% |
|
| Renal Failure Acute |
13.5% |
| Vomiting |
10.1% |
| Weight Decreased |
9.0% |
| Septic Shock |
5.6% |
| Transient Ischaemic Attack |
5.6% |
| Rash |
4.5% |
| Renal Impairment |
4.5% |
| Tachycardia |
4.5% |
| Thrombocytopenia |
4.5% |
| Urticaria |
4.5% |
| White Blood Cell Count Increased |
4.5% |
| Lichenoid Keratosis |
3.4% |
| Malaise |
3.4% |
| Myocardial Infarction |
3.4% |
| Pain |
3.4% |
| Pulmonary Embolism |
3.4% |
| Transaminases Increased |
3.4% |
| Vertigo |
3.4% |
| Weight Increased |
3.4% |
| Acute Pulmonary Oedema |
2.2% |
|
